Marcelo Garrido

Researcher Next ID · RN-010495

Researcher · Medicine

, Chile

Not currently recruitingFunding unknown

Research interests

Medicine

Gastric Cancer Management and Outcomes

Cancer Immunotherapy and Biomarkers

Esophageal Cancer Research and Treatment

Colorectal Cancer Treatments and Studies

Gastrointestinal Tumor Research and Treatment

First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial
The Lancet · 2021 · 10.1016/s0140-6736(21)00797-2
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
The Lancet · 2019 · 10.1016/s0140-6736(19)31149-3
Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial
Journal of Clinical Oncology · 2019 · 10.1200/jco.19.01307
Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer
JAMA Oncology · 2018 · 10.1001/jamaoncol.2018.0013
Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial
The Lancet · 2015 · 10.1016/s0140-6736(15)01281-7

No projects listed.